2021 DORIS definition of remission in SLE: final recommendations from an international task force
Ronald van Vollenhoven(Amsterdam University Medical Centers), Y K Onno Teng(Leiden University Medical Center), Marta Mosca(University of Pisa), Mandana Nikpour(The University of Sydney), Cindy Coney(Lupus Foundation of America), Matthias Schneider(Justus-Liebig-Universität Gießen), Ann E. Clarke(University of Calgary), Hermine I. Brunner(Cincinnati Children's Hospital Medical Center), Sandra Navarra(University of Santo Tomas), Anisur Rahman(University College London), Dimitrios T. Boumpas(National and Kapodistrian University of Athens), Y Schoenfeld(Sheba Medical Center), Alexandre E. Voskuyl(Amsterdam Neuroscience), Frédéric Houssiau(Cliniques Universitaires Saint-Luc), Guillermo Pons‐Estel(Hospital Provincial de Rosario), Manuel F. Ugarte‐Gil(Universidad Científica del Sur), Sang‐Cheol Bae(Unknown), George Βertsias(University Hospital of Heraklion), Eric F. Morand(Novartis (Switzerland)), Rebecca S. B. Fischer(Heinrich Heine University Düsseldorf), Ricard Cervera(Hospital Clínic de Barcelona), Caroline Gordon(University of Birmingham), Blanca Rubio, Ian N Bruce(University of Manchester), Bernadette van Leeuw, Andrea Doria(University of Padua), Michael M. Ward(National Institute of Neurological Disorders and Stroke), Bernardo A. Pons‐Estel(Hospital Provincial de Rosario), N. Costedoat‐Chalumeau(Délégation Paris 5), Eloísa Bonfá(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Hendrika Bootsma(University Medical Center Groningen), David Isenberg(Regenerative Medicine Institute), David Jayne(University of Cambridge), Raquel Faria(CUF Porto Hospital), Laurent Arnaud(Université Libre de Bruxelles), Michelle Petri(Johns Hopkins University), Graciela S. Alarcón(University of Alabama at Birmingham), Anca Askanase(Columbia University Irving Medical Center), Ruth Fritsch‐Stork(University Medical Center Utrecht), Murat İnanç(Istanbul University), Søren Jacobsen(University of Copenhagen), Maarten Limper(University Medical Center Utrecht), Thomas Dörner(German Rheumatism Research Centre), Martin Aringer(University Hospital Carl Gustav Carus), Annegret Kuhn(University of Passau), László Czirják(University of Pecs), Xavier Mariette(Inserm), Marzena Olesińska(National Institute of Geriatrics, Rheumatology and Rehabilitation), Josef S Smolen(Leiden University Medical Center), Juanita Romero‐Díaz(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán)
Cited by 340
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
|Annals of the Rheumatic Diseases|2019|2k
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
|New England Journal of Medicine|2010|1.7k
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
|Annals of the Rheumatic Diseases|2019|1.5k
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k